Biotech Analysts Agrawal and Schimmer, along with Chairman, President & CEO Weiss discuss the latest on Briumvi in Multiple Sclerosis on a conference call to be held on February 5 at 12 pm hosted by Cantor Fitzgerald.Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TGTX:
- TG Therapeutics price target lowered to $22 from $23 at JPMorgan
- TG Therapeutics price target raised to $39 from $37.50 at Ladenburg
- Biotech Alert: Searches spiking for these stocks today
- TG Therapeutics price target raised to $45 from $41 at H.C. Wainwright
- Unusually active option classes on open January 10th
